Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

NCI-Sponsored Leadership Focused on Clinical Trial Enrollment

Award Number: R50CA305011
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/07/2026
PERIOD OF PERFORMANCE END DATE: 08/31/2031

Group Awards By:

View Award Description

NCI-Sponsored Leadership Focused on Clinical Trial Enrollment - Project Summary/Abstract This five-year plan focuses on expanding cancer clinical trial enrollment to improve patient outcomes through leadership at both institutional and national levels, leveraging 15 years of experience in NCI clinical trials. As the inaugural Associate Director for Clinical Research, Director of Experimental Therapeutics, SWOG PI, and inaugural ETCTN PI at the University of Cincinnati Cancer Center, I oversee initiatives to expand our NCI portfolio, optimize clinical trial processes, enhance clinical trial access for all eligible patients, and mentor junior investigators to develop early-phase clinical trials through ETCTN/CTEP. Nationally, as SWOG Pancreas Subcommittee co-Chair and NCI Pancreas Task Force Member, I focus on novel clinical trial development, fostering collaborations across clinicians and researchers, and mentoring junior investigators to develop their NCTN careers. My institutional and national roles allow constant back-and-forth – applying lessons from one setting to the other, improving clinical trial processes and increasing accruals, developing connections between investigators at various sites. The specific new ventures during this next phase of my career are to: build dedicated institutional support for NCI clinical trials through clear funding lines and novel resource usage; provide focused mentorship to junior investigators at UCCC toward SWOG and ETCTN trials; increase accrual to clinical trials across our catchment area by aligning closely with our Community Outreach and Engagement team to address barriers and build community trust; develop the next generation of pancreatic cancer trials at SWOG by bringing novel therapies to the curative setting and incorporating ctDNA into adaptive trial designs. At both institutional and national levels, engagement of important stakeholders – community leaders and patient advocates – is a key focus, to expand the portfolio of trials and increase patient participation. My institution has supported me during my first six years here, and through this R50 funding, I will be able to dedicate the majority of my time to advance our overarching goal of increasing cancer clinical trial enrollment, creating a lasting impact on patient outcomes.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $240,272 )
2026	2026	CINCINNATI UNIV OF	2600 CLIFTON AVE	CINCINNATI	OH	45220	HAMILTON	USA	Cancer Treatment Research	000	1	9/7/2026	NEW	$240,272
														Subtotal = $240,272

Grand Total All Awards = $240,272

Top

All Categories

About

Search

Reports

Data Submission

Award Information

NCI-Sponsored Leadership Focused on Clinical Trial Enrollment

Award Number: R50CA305011

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/07/2026

PERIOD OF PERFORMANCE END DATE: 08/31/2031

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer